4basebio PLC (AIM:4BB)
London
· Delayed Price · Currency is GBP · Price in GBX 480.00
-25.00 (-4.95%)
Apr 28, 2026, 2:56 PM GMT
4basebio Market Cap
4basebio has a market cap or net worth of 78.16 million as of April 28, 2026. Its market cap has decreased by -47.15% in one year.
Market Cap
78.16M
Enterprise Value
67.48M
Revenue
1.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
480.00
Market Cap Chart
Since February 17, 2021, 4basebio's market cap has increased from 41.57M to 78.16M, an increase of 88.02%. That is a compound annual growth rate of 12.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 78.16M | -17.89% |
| Dec 31, 2025 | 95.19M | -38.57% |
| Dec 31, 2024 | 154.94M | 84.96% |
| Dec 29, 2023 | 83.77M | -4.21% |
| Dec 30, 2022 | 87.45M | 15.45% |
| Dec 31, 2021 | 75.75M | 82.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 83.80M |
| Bioventix | 88.82M |
| Ondine Biomedical | 64.94M |
| hVIVO | 53.24M |
| Hemogenyx Pharmaceuticals | 51.79M |
| Scancell Holdings | 134.91M |
| Poolbeg Pharma | 31.38M |
| Sareum Holdings | 28.99M |